https://www.selleckchem.com/pr....oducts/ide397-gsk-43
The first group of ponies developed neutralising antibody responses against all 9 serotypes, indicating that no cross-serotype interference occurred, while the second group developed robust neutralising antibody responses against the single serotype that were sustained at the same level throughout a 6-month study. The results support our previous data and further validate ECRA vaccines as a safe and efficacious replacement of current live vaccines.Several vaccines for SARS-CoV-2 are expected to be available in Australia in 20
Like
Comment
Share
